Drug-coated balloons are not inferior to drug-coated stents in the treatment of acute myocardial infarction and shorten the duration of dual antiplatelet treatment
Abstract. Background. Drug-coated balloons (DCBs) are an up-and-coming tactic in treating in-stent restenosis and coronary artery small vessel disease, but their efficacy in treating acute myocardial infarction needs to be further explored. Methods. A meta-analysis of 7 studies was conducted to make...
Saved in:
| Main Authors: | Jing Yang, Shuting Chang, Jing Liu, Guanzhao Zhang, Yue Wang, Baixue Zhang, Zifan Nie, Yuanbao Dong, Bo Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2022-12-01
|
| Series: | Emergency and Critical Care Medicine |
| Online Access: | http://journals.lww.com/10.1097/EC9.0000000000000050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
by: Jia-Hao Wen, et al.
Published: (2025-07-01) -
Debulking plus drug-coated balloon angioplasty versus
drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01) -
Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01) -
Drug-coated balloon in patients with in-stent restenosis: A prospective observational study
by: Shuvanan Ray, et al.
Published: (2025-03-01) -
Biofunctional coatings and drug-coated stents for restenosis therapy
by: Yanghui Wen, et al.
Published: (2024-12-01)